Koers GelStat Corp. Other OTC
Aandelen
GSAC
US3685331056
Farmaceutische producten
Omzet 2021 | 0,01 0,01 | Omzet 2022 | 0 0 | Marktkapitalisatie | 588K 549K |
---|---|---|---|---|---|
Nettowinst (verlies) 2021 | - 0 | Nettowinst (verlies) 2022 | - 0 | EV/omzet 2021 | 858.660.496 x |
Nettoschuld 2021 | 189K 176K | Nettoschuld 2022 | 361K 337K | EV/omzet 2022 | 407.113.588 x |
K/w-verhouding 2021 |
-12
x | K/w-verhouding 2022 |
-0,74
x | Werknemers | - |
Dividendrendement 2021 * |
-
| Dividendrendement 2022 |
-
| Vrij verhandelbaar | 90,48% |
Managers | Titel | Leeftijd | Van |
---|---|---|---|
Javier G. Acosta
CEO | Chief Executive Officer | - | - |
Besturend | Titel | Leeftijd | Van |
---|---|---|---|
Director/Board Member | 85 | 27-04-07 | |
Adrian Goldfarb
CHM | Chairman | 66 | 01-04-08 |
Paul W. Bucha
BRD | Director/Board Member | 81 | 04-11-11 |
Vaira. 1 jan. | Kapi. | |
---|---|---|
+33,25% | 704 mld. | |
+28,59% | 577 mld. | |
-3,55% | 348 mld. | |
+18,16% | 327 mld. | |
+4,36% | 288 mld. | |
+14,81% | 234 mld. | |
+4,93% | 198 mld. | |
-9,78% | 194 mld. | |
-3,69% | 147 mld. |